Their results support the molecular evidence that high MMP-1 mRNA expression and both aplotypes and polymorphisms of MMP-1 promoter gene may represent a risk factor in patients with invasive BC [51], and recognize MMP-1 as a prognostic marker in patients with invasive/metastatic BC [52-54]. This evidence concerns the gene MMP1 and breast cancer.